IBM Unveils Expanded Watson Platform for Health Cloud Capabilities

122

To date, the adoption of cloud in the healthcare industry has been a slow process due to concerns around security, regulatory and compliance. Cloud providers may offer the raw materials, but then customers must assemble and then validate materials themselves. Global adoption for cloud services in healthcare are expected to grow from $3.73 billion in 2015 to nearly $10 billion by 2020, according to MarketsandMarkets. The promise of cloud and cognitive capabilities has become a leading discussion in every IT strategy meeting as a platform for innovation in the future of healthcare delivery.

“As our clients look to accelerate the digitization of business processes, unlock new value from their health data and infuse new intelligence to transform their enterprise, they need a cloud platform that is built to specifically address the unique needs of the healthcare and life sciences industry,” said Lori Steele, IBM Global Managing Director of Healthcare and Life Sciences, at the 2017 Health Information Management Systems Society (HIMSS) conference in Orlando.

New Watson Health cloud offerings and capabilities include enhancements to the HIPAA-enabled data-platform-as-a-service, a new GxP edition of the platform, and new data center locations. These enhancements aim to help business executives and enterprise data scientists harness the power of big data and cognitive – further extending the reach of Watson Platform for Health, the industry’s only cloud data platform designed expressly for health and life sciences organizations.

“Stakes are high for health data, so a health cloud environment needs to be designed differently than one built to host email or online shopping,” said Rebecca Buisan, Director of Offering Management, Watson Platform for Health. “Security and safeguards at all levels are essential. But to help speed time to compliance – a platform needs to help clients address key industry regulatory needs – whether audit, consent management, de-identification, data governance or GxP practices. Combine that with the advanced analytics and Watson cognitive services, this data platform offers a place where Health and Life Sciences companies can truly innovate.”

Read the source article at IBM – United States.